Chronic Kidney Disease Flashcards

1
Q

What variables are used to calculate the eGFR?

A
  • Serum creatinine
  • Age
  • Gender
  • Ethnicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is stage 1 CKD classified as?

A

Greater than 90 ml/min, with some sign of kidney damage on other tests (if all the kidney tests* are normal, there is no CKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is stage 2 CKD classified as?

A

60-90 ml/min with some sign of kidney damage (if kidney tests* are normal, there is no CKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is stage 3a CKD classified as?

A

45-59 ml/min, a moderate reduction in kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is stage 3b CKD classified as?

A

30-44 ml/min, a moderate reduction in kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is stage 4 CKD classified as?

A

15-29 ml/min, a severe reduction in kidney function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is stage 5 CKD classified as?

A

Less than 15 ml/min, established kidney failure - dialysis or a kidney transplant may be needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are common causes of CKD?

A
  • diabetic nephropathy
  • chronic glomerulonephritis
  • chronic pyelonephritis
  • hypertension
  • adult polycystic kidney disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What can patients with CKD develop?

A
  • normocytic anaemia (when eGFR < 35ml/min)
  • low vitamin D (1-alpha hydroxylation normally occurs in the kidneys)
  • high phosphate
  • low calcium: due to lack of vitamin D, high phosphate
  • secondary hyperparathyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why does CKD lead to anaemia?

A
  • reduced erythropoietin levels - the most significant factor
  • reduced erythropoiesis due to toxic effects of uraemia on bone marrow
  • reduced absorption of iron
  • anorexia/nausea due to uraemia
  • reduced red cell survival (especially in haemodialysis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why does secondary hyperparathyroidism develop in patients with CKD?

A
  • vit D 1-alpha hydroxylation normally occurs in the kidneys =doesn’t happne
  • low calcium due to low vitamin D
  • high phosphate develops
  • parathyroid hormone activated to increase calcium levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical manifestation of secondary hyperparathyroidism in CKD?

A
  • Osteitis fibrosa cystica
  • Osteomalacia (low vit D)
  • Osteosclerosis
  • Osteoporosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the mineral bone disease management in CKD?

A
  • reduced dietary intake of phosphate is the first-line management
  • phosphate binders
  • vitamin D: alfacalcidol, calcitriol
  • parathyroidectomy may be needed in some cases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the management of anaemia in CKD?

A
  • optimisation of iron status (IV iron)

* administration of erythropoiesis-stimulating agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is used as a marker of CKD, especially for diabetic nephropathy?

A
  • Proteinuria

* Use the albumin:creatinine ratio

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is used first line for patients with proteinuria and CKD?

A

ACEi

*used for coexistent hypertension and CKD

17
Q

What can be used as an antihypertensive in CKD patients when their eGFR falls below 45ml/min?

A

*Furosemide

added benefit of lowering serum potassium

18
Q

What effect of an ACEi should be expected on eGFR and creatinine?

A

decrease in eGFR of up to 25% or a rise in creatinine of up to 30% is acceptable on ACEi

19
Q

What drugs should be avoided in renal failure?

A
  • Antibiotics: tetracycline, nitrofuratoin
  • NSAIDs
  • Lithium
  • Metformin